Roche Company

Roche is a pharmaceutical and diagnostics company that has been improving people's lives since its founding in 1896. It specializes in medicines for various medical fields, including oncology, virology, and immunology. Roche provides in-vitro diagnostics and drugs for cancer and transplantation, serving hospitals, research labs, private medical labs, practicing physicians, and patients. Its products include cancer treatments, such as Avastin, Herceptin, and MabThera, which are also effective in the treatment of rheumatoid arthritis, anemia, and osteoporosis. Roche conducts research and development as well as production related to molecular diagnostic reagents, test systems, and test kits. It also provides automated instruments, software, consumables, and IT solutions used in in-vitro diagnostics and research.

Employee Number: 10001+
Last Funding Type: Post-IPO Equity
Funding Status: IPO
Number Of Exists: 3
Acquisitions Number: Made Acquisitions
Total Funding: 7790500000.0
Last Funding Date: 2021-08-04
Industry: Pharmaceuticals
Estimated Revenue: $10B+
Investors Number: 3
Founded Date: 1896-01-15
Investment Stage: N/A
Technology: Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Investor Type: N/A
Headquarters: basel,
Zip: NA